Low Prevalence of Interleukin-6 haplotypes associated with a decreased risk of type 2 diabetes in Mexican subjects with a family history of type 2 diabetes

Archives of Medical Research

Volumn 44, Issue 7, 2013, Pages 529-534

  Zamora Ginez, Irma ^a   García Zapién, Alejandra Guadalupe ^b   Flores Martínez, Silvia Esperanza ^b   Sánchez Corona, José ^b   Baez Duarte, Blanca G ^a   Torres Rasgado, Enrique ^a   Romero, Jose R ^c   Pérez Fuentes, Ricardo ^a,b   Mendoza Carrera, Francisco ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Decreased risk; Family history; IL 6 haplotypes; Mexican subjects

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; FAMILY HISTORY; FEMALE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

EID: 84887203086     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.09.003     Document Type: Article

References (46)

1. Arslanian S.A., Bacha F., Saad R., et al. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in White youth. Diabetes Care 2005, 28:115-119.
2. Axelsen M., Smith U., Eriksson J.W., et al. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 1999, 131:27-31.
3. Rosenbaum M., Nonas C., Horlick M., et al. β-Cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 2004, 89:5469-5476.
4. Rodríguez-Morán M., Guerrero-Romero F. Hyperinsulinemia in healthy children and adolescents with a positive family history for type 2 diabetes. Pediatrics 2006, 118:e1516-e1522.
5. Zamora-Ginez I., Pérez-Fuentes R., Baez-Duarte B.G., et al. Risk factors for diabetes, but not for cardiovascular disease, are associated with family history of type 2 diabetes in subjects from central Mexico. Ann Hum Biol 2012, 39:102-107.
6. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(suppl 1):S62-S69. American Diabetes Association.
7. Schultz O., Oberhauser F., Saech J., et al. Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (A) levels in human subjects with rheumatoid diseases. PLoS ONE 2010, 5:1-7.
8. Ouchi N., Parker J., Lugus J., et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol [serial online] 2011, 11:85-97. Accessed February 23, 2012.
9. Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
10. Vozarova B., Weyer C., Hanson K., et al. Circulating interleukin-6 in relation to adiposity, insulin action and insulin secretion. Obes Res 2001, 9:414-417.
11. Frühbeck G., Gómez-Ambrosi J., Muruzábal F.J., et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001, 280:E827-E847.
12. Yasukawa K., Hirano T., Watanabe Y., et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987, 6:2939-2945.
13. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the Interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
14. Illig T., Bongardt F., Schöpfer A., et al. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. JCEM 2004, 89:5053-5058.
15. Hamid Y.H., Rose C.S., Urhammer S.A., et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005, 48:251-260.
16. Sehgal P.B., Zilberstein A., Ruggieri R., et al. Human chromosome 7 carries the ß2 interferon gene. PNAS 1986, 83:5219-5222.
17. Yang X., Jansson P.A., Pellme F., et al. Effect of the interleukin-6 (-174) G/C promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 2005, 13:813-817.
18. Di Renzo L., Bertoli A., Bigioni M., et al. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharma Design 2008, 14:2699-2706.
19. Mendoza-Carrera F., Ramírez-López G., Ayala-Martínez N.A., et al. Influence of CRP, IL-6, and TNFA gene polymorphisms on circulating levels of C-reactive protein in Mexican adolescents. Arch Med Res 2010, 41:472-477.
20. Huth C., Heid I.M., Vollmert C., et al. IL-6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes 2006, 55:2915-2921.
21. Rivera-Chávez F.A., Peters-Hybki D.L., Barber R.B., et al. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003, 20:218-223.
22. Zamora-Ginez I., Sánchez-Guillén M.C., Pérez-Fuentes R., et al. Association of interleukin-6 haplotypes, obesity, and metabolic abnormalities in a population of central Mexico. Lab Med 2010, 41:597-600.
23. Ramírez-López G., Portilla-de Buen E., Sánchez-Corona J., et al. Interleukin-6 polymorphisms are associated with obesity and hyperglycemia in Mexican adolescents. Arch Med Res 2013, 44:62-68.
24. Guerrero-Romero F., Rodríguez-Morán M., Pérez-Fuentes R., et al. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study. Metab Syndr Relat Disord 2008, 6:15-23.
25. Obesity: preventing and managing the global epidemic 2000, World Health Organization (WHO), WHO, Geneva, Tech Report Series No. 894.
26. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obesity Res 1998, 6(suppl 2):51-209. National Institutes of Health.
27. Verdalet-Guzmán I., Silva-Hernández E.R. Elementos antropométricos para evaluar el estado nutricional 2001, 15-27. Universidad Veracruzana, México. 1st ed.
28. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192. Date accessed: November 2011. University of Oxford. Diabetes Trials Unit. Homa Calculator Version 2.2.1. [Computer program]. http://www.dtu.ox.ac.uk/homacalculator/index.php.
29. Acosta A.M., Escalona M., Maíz A., et al. Determinación del índice de resistencia insulínica mediante HOMA en una población de la Región Metropolitana de Chile. Rev Med Chile 2002, 130:1227-1231.
30. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells (abstract). Nucleic Acid Res 1998, 16:1215.
32. Latkovskis G., Licis N., Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 2004, 31:207-213.
33. Salanti G., Amountza G., Ntzani E.E. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005, 13:840-848.
34. Excoffier L., Lischer H.E.L. Arlequin suite ver. 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Molec Ecol Resour 2010, 10:564-567.
35. Li C.C., Horvitz D.G. Some methods of estimating the inbreeding coefficient. Am J Hum Genet 1953, 5:107-117.
36. López X., Bouché C., Tatro E., et al. Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness. Diabetes Obes Metab 2009, 11:123-130.
37. Vaag A., Lehtovirta M., Thye-Rönn P., et al. Metabolic impact of a family history of type 2 diabetes. Results from a European multicentre study (EGIR). Diabetic Med 2001, 18:533-540.
38. Tripathy D., Lindholm E., Isomaa B., et al. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband. Am J Physiol Endocrinol Metab 2003, 285:E1297-E1303.
39. Mitchell B., Valdez R., Hazuda H., et al. Differences in prevalence of diabetes and impaired glucose tolerance according to maternal and paternal history of diabetes. Diabetes Care 1993, 16:1262-1267.
40. Bjornholt J.V., Erikssen G., Liestol K., et al. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000, 23:1255-1259.
41. Siewert S., Filipuzzi S., Codazzi L., et al. Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients. Rev Diabet Stud 2007, 4:177-184.
42. Meigs J.B., Cupples L.A., Wilson P.W. Parental transmission of type 2diabetes: the Framingham Offspring study. Diabetes 2000, 49:2201-2207.
43. Olaiz G., Rojas R., Barquera S., et al. Diabetes Mellitus. Encuesta Nacional de Salud 2000 (ENSA 2000). Tomo 2. La salud de los adultos 2003, 93-104. Mex Press, México.
44. Dedoussis G.V., Manios Y., Choumerianou D.M. The IL-6 gene G-174C polymorphism related to health indices in Greek primary school children. Obes Res 2004, 12:1037-1041.
45. Cardellini M., Perego L., D'Adamo M., et al. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes 2005, 28:2007-2012.
46. Testa R., Olivieri F., Bonfigli A.R., et al. Interleukin-6-174 G>C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Diabetes Res Clin Pract 2006, 71:299-305.